Viking Therapeutics' stock benefits as investors cheer weight-loss-drug results
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
/PRNewswire/ -- The global EMC shielding and test equipment market is expected to be valued at USD 8.4 billion in 2024 and is projected to reach USD 11.3...
RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its...
By Colin Kellaher Shares of RAPT Therapeutics plummeted more than 65% in premarket trading Tuesday after a serious adverse event prompted the U.S. Food and...
Investors looking for signs the FDA will let more patients use Sarepta Therapeutics’ Duchenne muscular dystrophy treatment got exactly that.